Skip to main content Deutsch
Radiation oncology fellow awarded for work about cervical cancer

(Vienna, 10-08-2015) Israel Fortin, radiation oncology fellow at the Department of Radiotherapy at the Medical University of Vienna, has been awarded by ASTRO (American Society for Radiation Oncology) for the best abstract with the Annual Meeting Travel Award in the Clinical category for the abstract titled:
“Distant Metastases in Locally Advanced Cervical Cancer Pattern of Relapse and Prognostic Factors: Early Results From the EMBRACE Study.” 

This work will allow for a better understanding of the course of distant metastases (in distant lymph nodes and organs) in locally advanced cervical cancer and provides the basis for adapting both radiotherapy and drug related treatment strategies to minimize distant nodal and distant metastases.

Israel Fortin is a radiation oncology fellow from Centre Hospitalier de l’Université de Montréal, Canada, where he completed his residency in 2014. Dr Fortin also completed a master degree in cellular and molecular cancer biology. His interest in gynaecology and brachytherapy has led him to a one year clinical and research fellowship in MRI guided adaptive brachytherapy in the Vienna Brachytherapy Group.

His fellowship has been supported by CARO (Canadian Association of Radiation Oncology) with a specific grant. Since 09/2014 he became actively involved in several projects, workshops and meetings related mainly to image guided gynaecologic brachytherapy within the Vienna University Research Group on Gynaecologic Radiation Oncology. Dr Fortin's work on the large EMBRACE study database focussed on systemic control in locally advanced cervical cancer and he analysed the pattern of relapse and prognostic factors in 751 patients. The EMBRACE study is a prospective international study on MRI guided brachytherapy (BT) in locally advanced cervical cancer with the department of radiation oncology Vienna as study center (

» Department of Radiotherapy